Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
342.6 SEK | -0.16% |
|
+5.68% | +20.07% |
11:17am | Novo Nordisk's Main Owner Leads $100 Million Financing of Biotech Firm Asceneuron | DJ |
11:14am | EQT Unit Invests in Biotechnology Company Asceneuron | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+20.07% | 38.38B | |
+1.69% | 36.11B | |
0.00% | 20.42B | |
+5.35% | 5.44B | |
+4.24% | 4.15B | |
+3.23% | 3.3B | |
+25.88% | 3.03B | |
-9.81% | 2.62B | |
+3.52% | 1.23B | |
+6.26% | 1.2B |
- Stock Market
- Equities
- EQT Stock
- News EQT AB
- S&P Begins EQT Coverage with A- Rating, Stable Outlook